Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TARSONS PRODUCTS Plunges 6%; BSE HEALTHCARE Index Down 0.1%
Wed, 14 Aug 9:26

TARSONS PRODUCTS Plunges 6%; BSE HEALTHCARE Index Down 0.1%Image source: asbe/www.istockphoto.com

TARSONS PRODUCTS share price has plunged 6% and is presently trading at Rs 456.0.

Meanwhile, the BSE HEALTHCARE index is at 41,000.5 (down 0.1%).

Among the top losers in the BSE HEALTHCARE index today are Divis Laboratories (down 2.2%) and ASTRAZENECA PHARMA (down 1.7%).

AJANTA PHARMA (up 6.4%) and ALEMBIC PHARMA (up 1.7%) are among the top gainers today.

Over the last one year, TARSONS PRODUCTS has moved down from Rs 561.1 to Rs 456.0, registering a loss of Rs 105.1 (down 18.7%).

On the other hand, the BSE HEALTHCARE index has moved up from 27,819.2 to 41,000.5, registering a gain of 47.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were GRANULES INDIA (up 129.7%), GSK Pharma (up 99.8%) and SUVEN PHARMACEUTICALS (up 98.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 78,980.1 .

The top gainers among the BSE Sensex today are Tech Mahindra (up 1.0%) and M&M (up 0.9%). The most traded stocks in the BSE Sensex are Tata Steel and Tata Motors.

In the meantime, NSE Nifty is at 24,146.7 . Hindalco and HCl Tech. are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,401.9 to 78,980.1, registering a gain of 13,578.2 points (up 20.8%).

TARSONS PRODUCTS Financial Update...

TARSONS PRODUCTS net profit fell 54.8% YoY to Rs 103 million for the quarter ended March 2024, compared to a profit of Rs 228 million a year ago. Net sales rose 28.8% to Rs 1,057 million during the period as against Rs 821 million in January-March 2023.

For the year ended March 2023, TARSONS PRODUCTS reported 19.8% decrease in net profit to Rs 807 million compared to net profit of Rs 1,007 million during FY22. Revenue of the company fell 5.8% to Rs 2,832 million during FY23.

The current Price to earnings ratio of TARSONS PRODUCTS, based on rolling 12 month earnings, stands at 56.9.


Equitymaster requests your view! Post a comment on "TARSONS PRODUCTS Plunges 6%; BSE HEALTHCARE Index Down 0.1%". Click here!